BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28717100)

  • 1. Inhibitory modulation of human estrogen receptor α and β activities by dicyclohexyl phthalate in human breast cancer cell lines.
    Okazaki H; Takeda S; Matsuo S; Matsumoto M; Furuta E; Kohro-Ikeda E; Aramaki H
    J Toxicol Sci; 2017; 42(4):417-425. PubMed ID: 28717100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphenol AF as an Inducer of Estrogen Receptor β (ERβ): Evidence for Anti-estrogenic Effects at Higher Concentrations in Human Breast Cancer Cells.
    Okazaki H; Takeda S; Kakizoe K; Taniguchi A; Tokuyasu M; Himeno T; Ishii H; Kohro-Ikeda E; Haraguchi K; Watanabe K; Aramaki H
    Biol Pharm Bull; 2017; 40(11):1909-1916. PubMed ID: 29093337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.
    Ni YD; Hong WJ; Zhou YC; Grossmann R; Zhao RQ
    Steroids; 2010 Mar; 75(3):245-51. PubMed ID: 20043933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.
    Sotoca AM; van den Berg H; Vervoort J; van der Saag P; Ström A; Gustafsson JA; Rietjens I; Murk AJ
    Toxicol Sci; 2008 Oct; 105(2):303-11. PubMed ID: 18644836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro.
    Okubo T; Suzuki T; Yokoyama Y; Kano K; Kano I
    Biol Pharm Bull; 2003 Aug; 26(8):1219-24. PubMed ID: 12913283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
    Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
    Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of silver nanoparticles on proliferation of estrogen-dependent MCF-7/BUS human breast cancer cells induced by butyl paraben or di-n-butyl phthalate.
    Roszak J; Smok-Pieniążek A; Domeradzka-Gajda K; Grobelny J; Tomaszewska E; Ranoszek-Soliwoda K; Celichowski G; Stępnik M
    Toxicol Appl Pharmacol; 2017 Dec; 337():12-21. PubMed ID: 29074358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of diphenyl phthalate as an agonist for estrogen receptor: an
    Lv C; Wei Z; Yue B; Xia N; Huang W; Yue Y; Li Z; Li T; Zhang X; Wang Y
    Toxicol Mech Methods; 2022 May; 32(4):280-287. PubMed ID: 34697989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor
    Hirao-Suzuki M; Takeda S; Okuda K; Takiguchi M; Yoshihara S
    Mol Pharmacol; 2019 Mar; 95(3):260-268. PubMed ID: 30552153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of wild-type estrogen receptor alpha and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells.
    Wu F; Safe S
    J Steroid Biochem Mol Biol; 2007 Jan; 103(1):1-9. PubMed ID: 17141713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k.
    Hong EJ; Ji YK; Choi KC; Manabe N; Jeung EB
    J Reprod Dev; 2005 Apr; 51(2):253-63. PubMed ID: 15883486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonistic and antagonistic effects of phthalates and their urinary metabolites on the steroid hormone receptors ERα, ERβ, and AR.
    Engel A; Buhrke T; Imber F; Jessel S; Seidel A; Völkel W; Lampen A
    Toxicol Lett; 2017 Aug; 277():54-63. PubMed ID: 28571686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
    Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
    Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma membrane estrogen receptors exist and functions as dimers.
    Razandi M; Pedram A; Merchenthaler I; Greene GL; Levin ER
    Mol Endocrinol; 2004 Dec; 18(12):2854-65. PubMed ID: 15231873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.